Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Newsletter
Wall Street Reform, GM Tomatoes and Chemical Regulation
Obama is gives a speech today in New York on the need to reform Wall Street. The Wall Street Journal reports on the debate over…
Op-Eds
The FDA Should Get Real
What happens when one of the most powerful regulatory bodies in the country orders a business to violate the agency’s own rules? If they…
Study
The Department of Defense Should Assess the Security Risks of Climate Change Policies
Full Document Available in PDF The Pentagon is perhaps the most influential…
Newsletter
Tax Day, Open Skies and Toyota’s Legal Tactics
Tax Day inspires out an array of protests and demonstrations. The U.S. and EU signed an “Open Skies” agreement last month, which purportedly allows airlines…
Newsletter
Unions, New Taxes and GM Crops
Andy Stern is leaving his post as head of the Service Employees International Union. The Obama Administration may soon propose a Value Added Tax (VAT).
Newsletter
Liquor Licensing, Off-label Drugs and Fannie & Freddie
A new proposal in New York to set up a “medallion” system of liquor-licensing will serve as a compromise between wine retailers and grocery store…